Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > COVID-19’s impact on hospital services | CIHI

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Dec 29, 2021 5:47pm

308 Views

Post# 34269157

RE:RE:RE:RE:COVID-19’s impact on hospital services | CIHI

Ya Im thinking that the pandemic is behind much of the general delays in enrollment vis a vis provedures being halted to make beds available...yet here we are. At tye doorstep of BTD. Not worried as I believe the FDA probably still sees cancer as a worthy malady in the face of the covid drama going on everywhere.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment